TheBrief.Health
A novel smart device for heart failure decongestion uses pressure-guided fluid redistribution to reduce congestion, potentially improving symptoms, lowering hospitalizations, and enabling remote monitoring.
Vær den første til at kommentere
Tilmeld dig nu og bliv en del af TheBrief.Health-fællesskabet!
Derefter 99 kr. / måned · Opsig når som helst.
500 episoder
THT 2026: First-In-Human Smart Implant—Heart Failure Decongestion
Sphingolipid to Steroid Ratio May Predict Asthma Exacerbations
Metabolomic profiling is emerging as a promising tool for predicting asthma exacerbations, enabling earlier risk identification, personalized treatment strategies, and potentially reducing hospitalizations through proactive disease management.
Early Promise of Flexible ECAP-Based Spinal Cord Stimulation for Chronic Pain Relief
ECAP-guided spinal cord stimulation enables real-time, adaptive pain management, offering more consistent symptom relief and reducing reliance on opioids for chronic pain patients.
Unlocking the Potential of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss and Heart Health
Emerging obesity treatments may deliver both weight-loss and cardiovascular benefits, offering new options to reduce heart disease risk while addressing the growing obesity epidemic.
Current Status of Retinal Diagnostics In Alzheimer’s Disease
Retinal imaging may offer a noninvasive way to detect early Alzheimer’s-related brain changes, supporting earlier screening, risk assessment, and referral before significant cognitive decline occurs.
Kommentarer
0Vær den første til at kommentere
Tilmeld dig nu og bliv en del af TheBrief.Health-fællesskabet!